Almost half of the pneumonias after allogeneic BMT are noninfectious in origin and are referred to as IPS. This group has obtained preliminary data in a mouse BMT model that support the hypothesis that IPS after allogeneic BMT is mediated by a cascade of inflammatory cytokines which can be conceptualized as three discrete steps. In step one, both total body irradiation and host alloantigens are factors in activating donor T cells at the time of marrow infusion. In step two, activated donor T cells secrete a number of cytokines, among them interferon-gamma, which is critical for the priming of pulmonary macrophages and monocytes. In step three, primed lung macrophages receive a second signal--either endogenous (gut-derived endotoxin) or exogenous (an inhaled environmental agent)-- and are triggered to secrete large, cytopathic amounts of inflammatory mediators such as TNF, IL-1, and nitric oxide (NO), which injure alveoli and the pulmonary interstitium. Their experimental plan will focus on the developmental pathophysiology of IPS as it relates to each of the three steps of this cytokine cascade.
Their specific aims are to analyze second signals that trigger inflammatory cytokines from pulmonary macrophages after allogeneic BMT and to test specific cytokine inhibitors for the prevention of resultant lung damage, to analyze the role of interferon from donor T cells in priming pulmonary macrophages after allogeneic BMT, and to analyze host TBI and donor/host histoincompatibility as factors in the IPS cytokine cascade following allogeneic BMT.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055162-03
Application #
2519529
Study Section
Special Emphasis Panel (ZHL1-CSR-M (M2))
Project Start
1995-09-15
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Hildebrandt, Gerhard C; Olkiewicz, Krystyna M; Corrion, Leigh et al. (2008) A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome. Biol Blood Marrow Transplant 14:385-96
Hildebrandt, Gerhard C; Olkiewicz, Krystyna M; Choi, Sung et al. (2005) Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood 105:2249-57
Gerbitz, Armin; Ewing, Patricia; Olkiewicz, Krystyna et al. (2005) A role for CD54 (intercellular adhesion molecule-1) in leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome. Transplantation 79:536-42
Gerbitz, Armin; Nickoloff, Brian J; Olkiewicz, Krystyna et al. (2004) A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome. Transplantation 78:494-502
Hildebrandt, Gerhard C; Olkiewicz, Krystyna M; Corrion, Leigh A et al. (2004) Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 104:586-93
Hildebrandt, Gerhard C; Corrion, Leigh A; Olkiewicz, Krystyna M et al. (2004) Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol 173:2050-9
Cooke, Kenneth R; Olkiewicz, Krystyna; Erickson, Nicole et al. (2002) The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 8:441-8
Teshima, T; Mach, N; Hill, G R et al. (2001) Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res 61:162-71
Reddy, P; Teshima, T; Kukuruga, M et al. (2001) Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 194:1433-40
Cooke, K R; Gerbitz, A; Crawford, J M et al. (2001) LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 107:1581-9

Showing the most recent 10 out of 24 publications